Today, the CAM technology has been developed into 3 different platform applications:
(1)	Cell Separation Technologies for cancer diagnostics - based on a differentiating property of cancer cells from normal (blood) cells for the detection of cancer cells in patients. The proprietary technology, called Cell Adhesion Matrix (CAM), is able to isolate aggressive cancer cells (Circulating Tumor Cells or CTCs) from whole blood for detection of all types of solid cancers. Vitatex CAM technology is used to develop cancer diagnostic blood tests that isolate cancerous cells in a few steps. Thus, Vitatex technology enables an increase of cancer detection sensitivity. In addition to cancer cells, CAM can also enrich some rare non-cancerous endothelial and occult fetal cells from whole blood.
	In addition to near-term cancer diagnostic applications, Vitatex Cell Separation Technologies also permit the development of: cancer therapeutic products (Vita-Filter™) products for the blood industry (removal of cancer cells from blood for transfusion and bone marrow transplantation) and other fields of medicine cardiovascular indications (testing for angiogenic propensity in heart disease) fetal occult cells (prenatal screening for genetic disorders)
(2)	Cell Separation Technologies for anti-cancer drug discovery - Our cell separation technologies have already identified several anti-angiogenic monoclonal antibodies for which Vitatex holds the exclusive U.S. license.
(3)	Cell Separation Technologies for discovery research -A blood test-based, discovery research platform for the identification of molecular signatures of numeral types of human diseases.